Impact of Clinical Pharmacist Interventions on Economic Outcomes in a Cardiology Setting in Qatar

<p>We sought to investigate the economic impact of preventing adverse events in a cardiology setting in Qatar as an effect of the clinical pharmacist as an intervention. This is a retrospective study of interventions by clinical pharmacists within an adult cardiology setting in a public health...

Full description

Saved in:
Bibliographic Details
Main Author: Daoud Al-Badriyeh (832403) (author)
Other Authors: Rasha Kaddoura (12506936) (author), Fatima AlMaraghi (17808704) (author), Ahmed Homosy (17808707) (author), Moza Al Hail (16532844) (author), Wessam El-Kassem (14829319) (author), Palli Valappila Abdul Rouf (16532847) (author), Abdalla Fadul (16007190) (author), Ahmed Mahfouz (737928) (author), Sumaya Alsaadi Alyafei (17380426) (author), Dina Abushanab (10696501) (author)
Published: 2023
Subjects:
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1864513529527140352
author Daoud Al-Badriyeh (832403)
author2 Rasha Kaddoura (12506936)
Fatima AlMaraghi (17808704)
Ahmed Homosy (17808707)
Moza Al Hail (16532844)
Wessam El-Kassem (14829319)
Palli Valappila Abdul Rouf (16532847)
Abdalla Fadul (16007190)
Ahmed Mahfouz (737928)
Sumaya Alsaadi Alyafei (17380426)
Dina Abushanab (10696501)
author2_role author
author
author
author
author
author
author
author
author
author
author_facet Daoud Al-Badriyeh (832403)
Rasha Kaddoura (12506936)
Fatima AlMaraghi (17808704)
Ahmed Homosy (17808707)
Moza Al Hail (16532844)
Wessam El-Kassem (14829319)
Palli Valappila Abdul Rouf (16532847)
Abdalla Fadul (16007190)
Ahmed Mahfouz (737928)
Sumaya Alsaadi Alyafei (17380426)
Dina Abushanab (10696501)
author_role author
dc.creator.none.fl_str_mv Daoud Al-Badriyeh (832403)
Rasha Kaddoura (12506936)
Fatima AlMaraghi (17808704)
Ahmed Homosy (17808707)
Moza Al Hail (16532844)
Wessam El-Kassem (14829319)
Palli Valappila Abdul Rouf (16532847)
Abdalla Fadul (16007190)
Ahmed Mahfouz (737928)
Sumaya Alsaadi Alyafei (17380426)
Dina Abushanab (10696501)
dc.date.none.fl_str_mv 2023-09-01T00:00:00Z
dc.identifier.none.fl_str_mv 10.1016/j.cpcardiol.2023.101838
dc.relation.none.fl_str_mv https://figshare.com/articles/journal_contribution/Impact_of_Clinical_Pharmacist_Interventions_on_Economic_Outcomes_in_a_Cardiology_Setting_in_Qatar/25019984
dc.rights.none.fl_str_mv CC BY 4.0
info:eu-repo/semantics/openAccess
dc.subject.none.fl_str_mv Biomedical and clinical sciences
Cardiovascular medicine and haematology
Pharmacology and pharmaceutical sciences
Economics
Applied economics
Clinical Pharmacist Interventions
Economic Outcomes
Cardiology
Qatar
dc.title.none.fl_str_mv Impact of Clinical Pharmacist Interventions on Economic Outcomes in a Cardiology Setting in Qatar
dc.type.none.fl_str_mv Text
Journal contribution
info:eu-repo/semantics/publishedVersion
text
contribution to journal
description <p>We sought to investigate the economic impact of preventing adverse events in a cardiology setting in Qatar as an effect of the clinical pharmacist as an intervention. This is a retrospective study of interventions by clinical pharmacists within an adult cardiology setting in a public healthcare setting (i.e Hamad Medical Corporation). The study included interventions that took place in March 2018, July 15, 2018 to August 15, 2018, and January 2019. The economic impact was measured via calculating the total benefit, defined as the sum of the cost savings and the cost avoidance. Sensitivity analyses were adopted to confirm the robustness of the results. The pharmacist intervened in 262 patients, resulting in 845 interventions, with appropriate therapy (58.6%) and dosing/administration (30.2%) being the most frequent categories of reported interventions. Cost savings and cost avoidance resulted in QAR-11,536 (USD-3169) and QAR1,607,484 (USD 441,616), respectively, yielding a total benefit of QAR1,595,948 (USD 438,447) per 3 months and QAR6,383,792 (USD 1,753,789) per a year.</p><h2>Other Information</h2> <p> Published in: Current Problems in Cardiology<br> License: <a href="http://creativecommons.org/licenses/by/4.0/" target="_blank">http://creativecommons.org/licenses/by/4.0/</a><br>See article on publisher's website: <a href="https://dx.doi.org/10.1016/j.cpcardiol.2023.101838" target="_blank">https://dx.doi.org/10.1016/j.cpcardiol.2023.101838</a></p>
eu_rights_str_mv openAccess
id Manara2_0583b9439cc2128bcb8b4410c935f39f
identifier_str_mv 10.1016/j.cpcardiol.2023.101838
network_acronym_str Manara2
network_name_str Manara2
oai_identifier_str oai:figshare.com:article/25019984
publishDate 2023
repository.mail.fl_str_mv
repository.name.fl_str_mv
repository_id_str
rights_invalid_str_mv CC BY 4.0
spelling Impact of Clinical Pharmacist Interventions on Economic Outcomes in a Cardiology Setting in QatarDaoud Al-Badriyeh (832403)Rasha Kaddoura (12506936)Fatima AlMaraghi (17808704)Ahmed Homosy (17808707)Moza Al Hail (16532844)Wessam El-Kassem (14829319)Palli Valappila Abdul Rouf (16532847)Abdalla Fadul (16007190)Ahmed Mahfouz (737928)Sumaya Alsaadi Alyafei (17380426)Dina Abushanab (10696501)Biomedical and clinical sciencesCardiovascular medicine and haematologyPharmacology and pharmaceutical sciencesEconomicsApplied economicsClinical Pharmacist InterventionsEconomic OutcomesCardiologyQatar<p>We sought to investigate the economic impact of preventing adverse events in a cardiology setting in Qatar as an effect of the clinical pharmacist as an intervention. This is a retrospective study of interventions by clinical pharmacists within an adult cardiology setting in a public healthcare setting (i.e Hamad Medical Corporation). The study included interventions that took place in March 2018, July 15, 2018 to August 15, 2018, and January 2019. The economic impact was measured via calculating the total benefit, defined as the sum of the cost savings and the cost avoidance. Sensitivity analyses were adopted to confirm the robustness of the results. The pharmacist intervened in 262 patients, resulting in 845 interventions, with appropriate therapy (58.6%) and dosing/administration (30.2%) being the most frequent categories of reported interventions. Cost savings and cost avoidance resulted in QAR-11,536 (USD-3169) and QAR1,607,484 (USD 441,616), respectively, yielding a total benefit of QAR1,595,948 (USD 438,447) per 3 months and QAR6,383,792 (USD 1,753,789) per a year.</p><h2>Other Information</h2> <p> Published in: Current Problems in Cardiology<br> License: <a href="http://creativecommons.org/licenses/by/4.0/" target="_blank">http://creativecommons.org/licenses/by/4.0/</a><br>See article on publisher's website: <a href="https://dx.doi.org/10.1016/j.cpcardiol.2023.101838" target="_blank">https://dx.doi.org/10.1016/j.cpcardiol.2023.101838</a></p>2023-09-01T00:00:00ZTextJournal contributioninfo:eu-repo/semantics/publishedVersiontextcontribution to journal10.1016/j.cpcardiol.2023.101838https://figshare.com/articles/journal_contribution/Impact_of_Clinical_Pharmacist_Interventions_on_Economic_Outcomes_in_a_Cardiology_Setting_in_Qatar/25019984CC BY 4.0info:eu-repo/semantics/openAccessoai:figshare.com:article/250199842023-09-01T00:00:00Z
spellingShingle Impact of Clinical Pharmacist Interventions on Economic Outcomes in a Cardiology Setting in Qatar
Daoud Al-Badriyeh (832403)
Biomedical and clinical sciences
Cardiovascular medicine and haematology
Pharmacology and pharmaceutical sciences
Economics
Applied economics
Clinical Pharmacist Interventions
Economic Outcomes
Cardiology
Qatar
status_str publishedVersion
title Impact of Clinical Pharmacist Interventions on Economic Outcomes in a Cardiology Setting in Qatar
title_full Impact of Clinical Pharmacist Interventions on Economic Outcomes in a Cardiology Setting in Qatar
title_fullStr Impact of Clinical Pharmacist Interventions on Economic Outcomes in a Cardiology Setting in Qatar
title_full_unstemmed Impact of Clinical Pharmacist Interventions on Economic Outcomes in a Cardiology Setting in Qatar
title_short Impact of Clinical Pharmacist Interventions on Economic Outcomes in a Cardiology Setting in Qatar
title_sort Impact of Clinical Pharmacist Interventions on Economic Outcomes in a Cardiology Setting in Qatar
topic Biomedical and clinical sciences
Cardiovascular medicine and haematology
Pharmacology and pharmaceutical sciences
Economics
Applied economics
Clinical Pharmacist Interventions
Economic Outcomes
Cardiology
Qatar